The epidermal growth factor receptor (EGFR), a type I tyrosine kinase receptor, has been associated with numerous malignancies including breast, lung, head and neck, bladder, colorectal, ovarian, and prostate carcinomas, as well as with the most common form of brain tumor, glioblastoma [1]. The gene discussed is EGFR; the disease is brain neoplasm.